BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31347379)

  • 1. Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus.
    Brickman CE; Propert KJ; Merlin JS; Liu JC; Eady S; Mcghee-Jez A; Ragin C; Grover S; Cohen RB; Gross R
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):934-940. PubMed ID: 31347379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
    Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
    Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes.
    Harrowfield J; Isenring E; Kiss N; Laing E; Lipson-Smith R; Britton B
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33557340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
    Biron VL; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Diagnosis and Multidisciplinary Management of Oropharyngeal Squamous Cell Carcinoma: State of the Art.
    Parvathaneni U; Lavertu P; Gibson MK; Glastonbury CM
    Radiographics; 2019; 39(7):2055-2068. PubMed ID: 31603733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of concomitant chemoradiotherapy in AJCC 7
    Lu DJ; Luu M; Nguyen AT; Shiao SL; Scher K; Mita A; Anderson E; Clair JM; Ho AS; Zumsteg ZS
    Oral Oncol; 2020 Nov; 110():104882. PubMed ID: 32650257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
    Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
    Marur S; Li S; Cmelak AJ; Gillison ML; Zhao WJ; Ferris RL; Westra WH; Gilbert J; Bauman JE; Wagner LI; Trevarthen DR; Balkrishna J; Murphy BA; Agrawal N; Colevas AD; Chung CH; Burtness B
    J Clin Oncol; 2017 Feb; 35(5):490-497. PubMed ID: 28029303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
    Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
    Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for oropharynx cancer in a cohort of HIV-infected veterans.
    Chew EY; Hartman CM; Richardson PA; Zevallos JP; Sikora AG; Kramer JR; Chiao EY
    Oral Oncol; 2017 May; 68():60-66. PubMed ID: 28438295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma.
    Grønhøj C; Jensen D; Dehlendorff C; Nørregaard C; Andersen E; Specht L; Charabi B; von Buchwald C
    Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):375-381. PubMed ID: 29526405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: a meta analysis].
    Yuanyuan X; Suling H; Quan Z; Shixun Z; Yucheng Y; Houyong K; Guohua H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 50(3):236-43. PubMed ID: 26268498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.
    Smith EA; Kumar B; Komurov K; Smith SM; Brown NV; Zhao S; Kumar P; Teknos TN; Wells SI
    Oncotarget; 2017 Apr; 8(14):23414-23426. PubMed ID: 28423581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.